Large Volume Parenteral Market

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
Large Volume Parenteral Market aims to provide a comprehensive presentation of the global market for Large Volume Parenteral (LVP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Parenteral (LVP). Large Volume Parenteral Market contains market size and forecasts of Large Volume Parenteral (LVP) in global, including the following market information:
Global Large Volume Parenteral (LVP) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Large Volume Parenteral (LVP) Market Sales, 2018-2023, 2024-2029, (M Units)
Global top five Large Volume Parenteral (LVP) companies in 2022 (%)
The global Large Volume Parenteral (LVP) market was valued at US$ 10830 million in 2022 and is projected to reach US$ 14180 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.
We surveyed the Large Volume Parenteral (LVP) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Large Volume Parenteral (LVP) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Large Volume Parenteral (LVP) Market Segment Percentages, by Type, 2022 (%)
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP
Global Large Volume Parenteral (LVP) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Large Volume Parenteral (LVP) Market Segment Percentages, by Application, 2022 (%)
Basic Infusion
Therapeutic Infusion
Nutritious Infusion
Global Large Volume Parenteral (LVP) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Large Volume Parenteral (LVP) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Large Volume Parenteral (LVP) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Large Volume Parenteral (LVP) revenues share in global market, 2022 (%)
Key companies Large Volume Parenteral (LVP) sales in global market, 2018-2023 (Estimated), (M Units)
Key companies Large Volume Parenteral (LVP) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Beximco Pharma
Albert David
PSI Ltd
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs
Outline of Major Chapters:
Chapter 1: Introduces the definition of Large Volume Parenteral (LVP), market overview.
Chapter 2: Global Large Volume Parenteral (LVP) market size in revenue and volume.
Chapter 3: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Large Volume Parenteral (LVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Large Volume Parenteral (LVP) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.